Literature DB >> 6407080

Involvement of protein in scrapie agent infectivity.

A J Lax, G C Millson, E J Manning.   

Abstract

The nature of the causative agent of scrapie is not known. Previous work has demonstrated that nuclease digestion does not inactivate scrapie infectivity, but there are conflicting reports about the effects of proteases. It is shown here that the broad range protease, proteinase K, reduces scrapie infectivity under all conditions tested. Control experiments demonstrated that the loss of infectivity is not artefactual and results from protein breakdown. Proteolytic digestion in the presence of detergent greatly increases proteolysis, but does not lead to a further loss of infectivity. This suggests that the protein involved may be a surface component, but whether the component is an integral or secondary part of the agent is not known.

Mesh:

Substances:

Year:  1983        PMID: 6407080

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  6 in total

1.  Characterization of major peptides in Creutzfeldt-Jakob disease and scrapie.

Authors:  T Sklaviadis; L Manuelidis; E E Manuelidis
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

2.  Physical properties of the Creutzfeldt-Jakob disease agent.

Authors:  T K Sklaviadis; L Manuelidis; E E Manuelidis
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

3.  Molecular hybridization studies with scrapie brain nucleic acids. I. Search for specific DNA sequences.

Authors:  T Borrás; C J Gibbs
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

4.  Inactivation of the scrapie agent by pronase.

Authors:  H J Cho
Journal:  Can J Comp Med       Date:  1983-10

Review 5.  Fate of prions in soil: a review.

Authors:  Christen B Smith; Clarissa J Booth; Joel A Pedersen
Journal:  J Environ Qual       Date:  2011 Mar-Apr       Impact factor: 2.751

6.  Evidence suggesting that PrP is not the infectious agent in Creutzfeldt-Jakob disease.

Authors:  L Manuelidis; T Sklaviadis; E E Manuelidis
Journal:  EMBO J       Date:  1987-02       Impact factor: 11.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.